OncoLink Cancer Treatment and Resources

Satisfaction and anxiety are improved with the use of an easy-to-read informed consent document: a randomized multi-group study



Li Liu, MD

University of Pennsylvania Cancer
Last Modified: May 12, 2001

Presenter: P. C. Raich
Affiliation: AMC Cancer Research Center, Denver, CO

Background:

    Informed consent is a process in which the patient is given all the information needed to decide whether to participate in a clincal trial. The signing of the informed consent document by both the patient and the investigator is the written verification of this process. Readability of most of the consents remains a problem for the US population in which half has reading skills at an 8th grade level or below.

Materials and Methods:

  • 226 patients who were randomly assigned to either standard consent form (13th grade level) or an easy to read form (8th grade level) were evaluated
  • Multiple institution study including 46 sites involved with three clinical trials from the NCCTG, ECOG, and CALGB.
  • Comprehension of the consent, anxiety associated with the process, and satisfaction with the process were all evaluated.

Results:

  • Comprehension of consent content was similar between two groups
  • More satisfaction and decreased anxiety were observed in easy
  • to
  • read group

Authors' Conclusions

  • Easy readability was associated with enhanced satisfaction and reduced anxiety
  • Participation of clinical trials maybe enhanced by patient's satisfaction and less anxiety with informed consent process

Clinical/Scientific Implications:

  • The signing of the informed consent form does not, however, end the process of consent
  • The investigator is obligated to continue to provide relevant information to the subject, answer questions, and ensure understanding throughout the duration of the study
  • Continued education of patients who are enrolled in the clinical trials may also play a positive role in patient's satisfaction

Saturday | Sunday | Monday | Tuesday

OncoLink ASCO 2001 coverage is provided by an unrestricted educational grant from Amgen

OncoLink I wish u knew...

Learning as much as you can about your cancer diagnosis gives you the tools you need to make treatment decisions. Read more.

Cancer Types
Bone Cancer
Brain Tumors
Breast Cancer
Carcinoid Tumors
Endocrine System Cancers
Gastrointestinal Cancers
Gynecologic Cancers
Head and Neck Cancers
Leukemia
Lung Cancers
Lymphomas
Myelomas
Pediatric Cancers
Penile Cancer
Prostate Cancer
Sarcomas
Skin Cancers
Testicular Cancer
Thyroid Cancer
Urinary Tract Cancers
OncoLink Vet

Cancer Treatment
Biologic Therapy
Bone Marrow Transplants
Chemotherapy

Clinical Trials
Complementary Medicine
Gene Therapy
General Treatment Concerns
Hormone Therapy
PDT Center
Proton Therapy
Radiation Oncology
Surgical Oncology
Targeted Therapies
Vaccine Therapies

Cancer Support
Caregivers
Hospice Care and Bereavement
Nutrition and Cancer
Sexuality & Fertility
Side Effects
Support
Survivorship
Exercise and Cancer

Cancer Resources
Cancer News
OncoLink University
Nurses' Notes
Conferences
Newly Diagnosed Patients
Causes and Prevention
Legal and Financial Information for Patients
LGBT Resources
NCI Resources
Global Resources
Cancer Resource List
Resources for Young Adults

OncoLink Media Library
OncoLink TV
Book, Music and Video Reviews


Ask the Experts
Brown Bag Chat
Tracy's Corner

About OncoLink
About OncoLink
Giving to OncoLink
Contact Information
Usage Policy
Editorial Board
How to Partner with OncoLink
Link to OncoLink
Mission Statement

OncoLink Cancer Resources RSS What's New RSS